Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer

ISSN Print: 2168-1546
ISSN Online: 2168-1554
www.scirp.org/journal/jibtva
E-mail: jibtva@scirp.org

Citations

"Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer"
written by Zhiwei Hu,
published by Journal of Immune Based Therapies, Vaccines and Antimicrobials, Vol.2 No.1, 2013

has been cited by the following article(s):

[1]	A high-throughput RNAi screening identifies olfactory receptor signaling as a novel immune checkpoint in solid tumors
	2023

[2]	Using CAR-NK cells to overcome the host resistance to antibody immunotherapy and immune checkpoint blockade therapy
	Successes and Challenges of NK Immunotherapy, 2021

[3]	Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
	2020

[4]	Dissecting the NK cell population in hematological cancers confirms the presence of tumor cells and their impact on NK population function
	2020

[5]	Investigating the maintenance of desmoid tumors beyond beta-catenin
	2019

[6]	Non-genetically improving the natural cytotoxicity of natural killer (NK) cells
	2019

[7]	Therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated …
	Antibodies, 2018

[8]	Therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated human …
	Antibodies, 2018

[9]	Expansion of allogeneic nk cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
	Theranostics, 2018

[10]	The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy
	Journal of thoracic disease, 2017

[1]	Successes and Challenges of NK Immunotherapy 2021 DOI:10.1016/B978-0-12-824375-6.00010-2

[2]	Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells Frontiers in Immunology, 2020 DOI:10.3389/fimmu.2019.03026

[3]	Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function Vaccines, 2020 DOI:10.3390/vaccines8040727

[4]	Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function Vaccines, 2020 DOI:10.3390/vaccines8040727

[5]	Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases Antibodies, 2018 DOI:10.3390/antib7010008

[6]	Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases Antibodies, 2018 DOI:10.3390/antib7010008